A new study published in the journal Nature Communications suggests that blocking a druggable family of proteins can prevent rapid resistance to vemurafenib, a commonly used treatment for advanced melanoma. Scientists at the Cancer Research UK Manchester Institute, based at the University of Manchester, have revealed the MLK family of four enzymes 'undoes' the tumour-shrinking effects of vemurafenib**. Around half of metastatic melanomas - aggressive ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1t9FicI
No comments:
Post a Comment